Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria… - Nature reviews …, 2015 - nature.com
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article …
and overall survival has not changed significantly for several decades. In this Opinion article …
Triple negative breast cancer: A thorough review of biomarkers
JL da Silva, NCC Nunes, P Izetti… - Critical reviews in …, 2020 - Elsevier
Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of
expression of estrogen receptor (ER), progesterone receptor (PR) and HER2 protein. The …
expression of estrogen receptor (ER), progesterone receptor (PR) and HER2 protein. The …
Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility
M Köbel, BM Ronnett, N Singh, RA Soslow… - International journal …, 2019 - journals.lww.com
P53 immunohistochemistry has evolved into an accurate surrogate reflecting the underlying
TP53 mutation status of a tumor, and has utility in the diagnostic workup of endometrial …
TP53 mutation status of a tumor, and has utility in the diagnostic workup of endometrial …
Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas
Purpose Histologic transformation of EGFR mutant lung adenocarcinoma (LADC) into small-
cell lung cancer (SCLC) has been described as one of the major resistant mechanisms for …
cell lung cancer (SCLC) has been described as one of the major resistant mechanisms for …
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
M Köbel, AM Piskorz, S Lee, S Lui… - The Journal of …, 2016 - Wiley Online Library
TP53 mutations are ubiquitous in high‐grade serous ovarian carcinomas (HGSOC), and the
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Ovarian cancer is the fifth cause of cancer-related death in women and comprises a
histologically and genetically broad range of tumours, including those of epithelial, sex cord …
histologically and genetically broad range of tumours, including those of epithelial, sex cord …
The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
J McAlpine, A Leon‐Castillo… - The Journal of pathology, 2018 - Wiley Online Library
Endometrial cancer is a clinically heterogeneous disease and it is becoming increasingly
clear that this heterogeneity may be a function of the diversity of the underlying molecular …
clear that this heterogeneity may be a function of the diversity of the underlying molecular …
[HTML][HTML] Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
RJ Kurman - Annals of Oncology, 2013 - Elsevier
A new paradigm for the pathogenesis of ovarian cancer has recently been proposed which
helps to explain persistent problems in describing the development and diverse morphology …
helps to explain persistent problems in describing the development and diverse morphology …
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth
C Tombari, A Zannini, R Bertolio, S Pedretti… - nature …, 2023 - nature.com
Reprogramming of amino acid metabolism, sustained by oncogenic signaling, is crucial for
cancer cell survival under nutrient limitation. Here we discovered that missense mutant p53 …
cancer cell survival under nutrient limitation. Here we discovered that missense mutant p53 …
From conventional to precision therapy in canine mammary cancer: a comprehensive review
G Valdivia, Á Alonso-Diez, D Pérez-Alenza… - Frontiers in veterinary …, 2021 - frontiersin.org
Canine mammary tumors (CMTs) are the most common neoplasm in intact female dogs.
Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the …
Canine mammary cancer (CMC) represents 50% of CMTs, and besides surgery, which is the …